According to the latest status from June 2024, Intra-Cellular Therapies paid a total of 0 USD per share in dividends within the last 12 months. With the current Intra-Cellular Therapies price of 71.09 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Intra-Cellular Therapies has been increasing the dividend for 0 years.
Over the past 10 years, Intra-Cellular Therapies has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Intra-Cellular Therapies’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Examining Intra-Cellular Therapies's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Intra-Cellular Therapies's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Changes in Intra-Cellular Therapies’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
The Intra-Cellular Therapies stock can be added to a savings plan with the following providers: Trade Republic
Over the past 12 months, Intra-Cellular Therapies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intra-Cellular Therapies is expected to pay a dividend of 0 USD.
The current dividend yield of Intra-Cellular Therapies is .
Intra-Cellular Therapies pays a quarterly dividend. This is distributed in the months of .
Intra-Cellular Therapies paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
Intra-Cellular Therapies is assigned to the 'Health' sector.
To receive the latest dividend of Intra-Cellular Therapies from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.
The last dividend was paid out on 6/27/2024.
In the year 2023, Intra-Cellular Therapies distributed 0 USD as dividends.
The dividends of Intra-Cellular Therapies are distributed in USD.
Our stock analysis for Intra-Cellular Therapies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intra-Cellular Therapies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
